cryptococcosis

ICD-10 Codes

Related ICD-10:

Description

What is Cryptococcosis?

Cryptococcosis is a potentially fatal fungal infection caused by inhaling fungal spores from the environment, specifically from soil contaminated with the encapsulated yeasts Cryptococcus neoformans or C. gattii. This infection can affect various parts of the body, including the lungs, brain, skin, bones, and viscera.

Symptoms

The symptoms of cryptococcosis depend on where the fungus infects you:

  • Lung Infections: Can cause pneumonia-like symptoms, such as coughing, difficulty breathing, chest pain, and fever.
  • Central Nervous System (CNS) Infections: Can cause meningitis-like symptoms, including headache, fever, neck pain, nausea and vomiting, light sensitivity, and confusion or changes in mental state.
  • Disseminated Infections: Can cause symptoms in many parts of the body.

Causes and Risk Factors

The two species that commonly cause infections are Cryptococcus neoformans (found globally) and C. gattii (mostly found in tropical and subtropical areas). People with weakened immune systems, such as those with HIV/AIDS, are at higher risk of developing cryptococcosis.

Prevalence

Cryptococcosis is a leading cause of death among people with HIV/AIDS in parts of the world. It is an important opportunistic infection in humans, particularly in immunocompromised populations.

References

  • [1] Cryptococcus neoformans and C. gattii are the two species that commonly cause infections.
  • [2-3] The symptoms of cryptococcosis depend on where the fungus infects you.
  • [4-5] People with weakened immune systems, such as those with HIV/AIDS, are at higher risk of developing cryptococcosis.
  • [6] Cryptococcosis is a leading cause of death among people with HIV/AIDS in parts of the world.

Additional Characteristics

  • A potentially fatal fungal infection caused by inhaling fungal spores from the environment.
  • Can affect various parts of the body, including the lungs, brain, skin, bones, and viscera.
  • Symptoms depend on where the fungus infects you: lung infections cause pneumonia-like symptoms, CNS infections cause meningitis-like symptoms, and disseminated infections cause symptoms in many parts of the body.
  • AIDS, are at higher risk of developing cryptococcosis.
  • AIDS in parts of the world.

Signs and Symptoms

Symptoms of Cryptococcosis

Cryptococcosis, an infection caused by the Cryptococcus fungus, can manifest in various ways depending on which part of the body is affected. Here are some common signs and symptoms:

  • Lung Infections:
    • Cough
    • Shortness of breath
    • Chest pain
    • Fever
  • Cryptococcal Meningitis:
    • Headache
    • Neck pain
    • Sensitivity to light
    • Confusion or altered behavior

Additionally, people with cryptococcosis may experience:

  • Fever
  • Skin lesions
  • Headache and altered mental status

It's essential to note that symptoms can vary depending on the individual and the severity of the infection. If you have a weakened immune system (e.g., HIV/AIDS, cancer patients undergoing chemotherapy), it's crucial to seek medical attention if you experience any of these symptoms.

References:

  • [13] Symptoms of lung infections can include cough, shortness of breath, chest pain, and fever.
  • [13] Symptoms of cryptococcal meningitis can include headache, neck pain, sensitivity to light and confusion, or altered behavior.
  • [14] Symptoms and signs include fever, cough, skin lesions, headache and altered mental status.
  • [15] Cerebrospinal fluid (CSF) culture and other tests to check for signs of infection; Chest x-ray

Additional Symptoms

  • Skin lesions
  • Headache and altered mental status
  • fever

Diagnostic Tests

Diagnostic Tests for Cryptococcosis

Cryptococcosis, a fungal infection caused by Cryptococcus neoformans, can be diagnosed through various laboratory tests. The diagnostic process typically involves a combination of clinical evaluation, imaging studies, and laboratory tests to confirm the presence of the fungus.

Laboratory Tests

  • Culture: Culture is considered the gold standard for diagnosing cryptococcal infection (5). It involves growing the fungus from a sample of body fluid or tissue in a laboratory. This test can take several days to weeks to produce results.
  • Antigen tests: Antigen tests, such as latex agglutination or ELISA, detect the presence of cryptococcal capsular polysaccharide in serum and cerebrospinal fluid (1). These tests have high sensitivity and specificity but may not be available in all laboratories.
  • Microscopy: Microscopic examination of cerebrospinal fluid (CSF) or tissue can also be used to diagnose cryptococcosis (7).

Clinical Evaluation

In addition to laboratory tests, clinical evaluation plays a crucial role in diagnosing cryptococcosis. Healthcare providers will assess the patient's medical history, symptoms, and physical examination findings to determine the likelihood of cryptococcal infection.

  • Symptoms: Symptoms of cryptococcosis can include fever, headache, confusion, and respiratory or neurological problems (15).
  • Imaging studies: Imaging studies, such as CT or MRI scans, may be used to evaluate the extent of disease in the brain or lungs (9).

Targeted Screening

Targeted screening is essential for preventing deadly infections in people with HIV/AIDS. Regular testing can help identify individuals at risk and prevent cryptococcosis from progressing to severe stages.

In conclusion, diagnosing cryptococcosis requires a combination of laboratory tests, clinical evaluation, and imaging studies. Targeted screening is crucial for preventing cryptococcosis in high-risk populations.

References:

  1. [Context 1]
  2. [Context 2]
  3. [Context 3]
  4. [Context 4]
  5. [Context 5]
  6. [Context 6]
  7. [Context 7]
  8. [Context 8]
  9. [Context 9]
  10. [Context 15]

Additional Diagnostic Tests

  • Microscopy
  • Culture
  • Antigen tests

Treatment

Current Antifungal Treatments for Cryptococcosis

Cryptococcosis, a serious fungal infection, has limited treatment options. The current antifungal arsenal available for its treatment includes three primary drugs:

  • Amphotericin B deoxycholate (AMB): This is the drug of choice for initial therapy in disseminated or CNS cryptococcosis [1]. It can be used alone or in combination with other medications.
  • Flucytosine: This antifungal agent is often used in combination with Amphotericin B to treat cryptococcal infections [3].
  • Fluconazole: This medication is also effective against cryptococcosis, particularly for treating cryptococcal pneumonia [8].

Treatment Regimens

The preferred treatment regimen for cryptococcosis involves the use of Liposomal amphotericin B (IV 3–4 mg/kg daily) plus flucytosine (25 mg/kg orally four times daily) for 2 weeks [5]. This combination has been shown to be effective in treating disseminated or CNS cryptococcosis.

Additional Treatment Options

Other antifungal medications, such as Itraconazole and Fluconazole, have also been used to treat cryptococcosis. However, their effectiveness may vary depending on the severity of the infection and the patient's HIV status [9].

Duration of Treatment

People with cryptococcosis typically require prescription antifungal medication for at least 6 months, often longer. The duration of treatment depends on the type and severity of the infection, as well as the patient's HIV status.

References:

[1] May 31, 2024 — The drug of choice (DOC) for initial therapy in disseminated or CNS cryptococcosis is amphotericin B. [3] Three antifungal drugs are of benefit in the treatment of cryptococcal meningitis in patients with AIDS: amphotericin B, fluconazole, and flucytosine. [5] Oct 29, 2024 — Liposomal amphotericin B (IV 3–4 mg/kg daily) plus flucytosine (25 mg/kg orally four times daily) for 2 weeks is the regimen preferred and recommended. [8] For cryptococcal pneumonia, use fluconazole (6–12 mg/kg per day orally) for 6–12 months (B-II). [9] Itraconazole is promising for the treatment of cryptococcosis in patients with and without the acquired immunodeficiency syndrome.

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Cryptococcosis

Cryptococcosis, an infectious disease caused by the encapsulated fungi Cryptococcus neoformans and Cryptococcus gattii, can be challenging to diagnose due to its similarity with other conditions. The differential diagnosis for cryptococcosis includes:

  • Histoplasmosis: This fungal infection can cause similar symptoms, such as pneumonia and meningitis.
  • Blastomycosis: Another type of fungal infection that can present with skin lesions, lung disease, and central nervous system involvement.
  • Pneumocystis jiroveci Pneumonia (PJP): A common opportunistic infection in immunocompromised individuals, which can cause pneumonia and other respiratory symptoms.
  • Acanthamoeba Infection: A rare but serious condition that can cause skin lesions, eye infections, and brain abscesses.
  • Basal Cell Carcinoma: A type of skin cancer that can mimic the appearance of cryptococcosis.
  • Lipomas: Benign tumors that can be mistaken for cryptococcal lesions.
  • Molluscum Contagiosum: A viral infection that causes small, pearly lesions on the skin.

Key Points to Consider

  • The diagnosis of cryptococcosis is often delayed due to its similarity with other conditions.
  • A thorough medical history and physical examination are essential in making a differential diagnosis.
  • Laboratory tests, such as culture and histopathology, can help confirm the diagnosis of cryptococcosis.
  • Imaging studies, like MRI or CT scans, may be necessary to evaluate the extent of disease.

References

  • [6] Mucicarmine positivity discriminates cryptococcus from other fungal infections, such as histoplasmosis and blastomycosis.
  • [13] The differential diagnosis for cryptococcosis includes progressive disease due to persistent immune deficiency, failure of antimicrobial therapy, coinfection with other opportunistic infections (OIs), and drug toxicity.
  • [14] Cryptococcus neoformans meningoencephalitis is the most frequently encountered manifestation of cryptococcosis.

Additional Differential Diagnoses

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_7876
owl#annotatedSource
t398703
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:12053
core#notation
DOID:12053
oboInOwl#hasDbXref
UMLS_CUI:C0010414
core#exactMatch
MESH:D003453
IAO_0000115
An opportunistic mycosis that results_in fungal infection and has_material_basis_in Cryptococcus neoformans or Cryptococcus gattii.
oboInOwl#hasExactSynonym
torulosis
rdf-schema#label
cryptococcosis
oboInOwl#hasRelatedSynonym
cryptococcus neoformans infection
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_2473
relatedICD
http://example.org/icd10/B45
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.